Belgian Research Reveals Extent Of EU’s Digital Health Tech Reimbursement Labyrinth
National reimbursement schemes for digital tech are not just varied but inconsistent in Europe
Executive Summary
Digital medical products pose challenges beyond the scope of existing evaluation frameworks for medical devices, triggering proactive responses at both a national and EU-level. A report by Belgian researchers shows just how complex the situation is.
You may also be interested in...
Future Proofing HTA: How Systems Must Adapt To AI And Digital Medtech
Artificial intelligence is a major advancement in medtech due to its ability to rapidly adapt, improve and learn. However, value assessment models must also reform to keep up with this technology in the medtech space, an HTA expert told Medtech Insight.
Germany’s Digital Health Fast-Track Scheme: What Manufacturers Need To Know
Understanding the German reimbursement system is crucial for any medtech firm eyeing the European market, and healthtech innovators in particular may benefit from its fast-track digital health app scheme. But how does the scheme work, and who can apply?
EU HTA Regulation: Taskforce To Develop Evaluation Framework For Digital Medtech
Several national health technology assessment bodies in Europe have joined forces with EU-level organizations to develop recommendations on harmonized evaluation guidelines for digital medical devices under the upcoming EU Regulation on HTA.